HPLC-MS Assay for the Determination of Bromhexine in Human Plasma and Application to Bioequivalence Studies

ZHANG Wen,FENG Fang,WANG Ya
DOI: https://doi.org/10.3969/j.issn.1673-7806.2008.02.011
2008-01-01
Abstract:Objective:To establish an analytical method for the determination of bromhexine in human plasma with HPLC-MS, and to evaluate the pharmacokinetics, relative-bioavailability and bioequivalence of bromhexine of tested bromhexine hydrochloride / cefaclor tablet in healthy volunteers.Methods: 20 male healthy volunteers were divided into 2 groups randomly. After a single crossover oral dose of test or reference formulations containing 16 mg bromhexine (equaling to 17.5 mg bromhexine hydrochloride) and 500 mg cefaclor, the concentration of bromhexine in plasma samples were determined by HPLC-MS.Results:The bromhexine in test and reference formulations were Cmax: (34.30 ± 7.02) and (35.06 ±8.39) ng·mL-1, tmax (1.4 ± 0.6) and (1.0 ± 0.5) h,t1/2 (5.75 ± 0.82) and (6.12 ± 0.62) h, CL (135.8 ± 14.6) and (129.2 ± 16.4) L·h-1, AUC0-24(125.2 ± 16.1) and (119.8 ± 16.1) ng·h·mL-1, respectively. The relative bioavailability of bromhexine was (106.0 ± 15.3)%. Conclusion:The method is proved to be accurate, sensitive and rapid. Bromhexine in the test formulation is bioequivalent to the reference formulation.
What problem does this paper attempt to address?